We are live on ! Find out more
TNYA icon

Tenaya Therapeutics
TNYA

47 hedge funds and large institutions have $668M invested in Tenaya Therapeutics in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 2 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,000% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 2

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

3.64% more ownership

Funds ownership: 82% → 85.65% (+3.6%)

0% more funds holding

Funds holding: 47 → 47 (0)

4% less capital invested

Capital invested by funds: $693M → $668M (-$25.8M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
47
Holders Change
–
Holders Change %
0%
% of All Funds
0.72%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
8
Increased
22
Reduced
2
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$13.5M
2
BlackRock
BlackRock
New York
+$5.52M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$4.8M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.17M
5
State Street
State Street
Massachusetts
+$713K

Top Sellers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
-$3.1M
2
Millennium Management
Millennium Management
New York
-$2.21M
3
CCM
CAAS Capital Management
New York
-$1.03M
4
GCM
Ghisallo Capital Management
Massachusetts
-$310K
5
SG Americas Securities
SG Americas Securities
New York
-$129K
Name Holding Trade Value Shares
Change 		Change in
Stake
CG
1
Column Group
California
$178M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$107M +$13.5M +620,255 +12%
CC
3
Casdin Capital
New York
$68M – – –
RCM
4
RA Capital Management
Massachusetts
$67.3M – – –
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$55.6M +$4.8M +220,394 +8%
RI
6
RTW Investments
New York
$46.6M – – –
BlackRock
7
BlackRock
New York
$35.5M +$5.52M +253,225 +16%
AI
8
Alphabet Inc
California
$17.4M – – –
EC
9
Euclidean Capital
New York
$17.4M – – –
DTC
10
Deep Track Capital
Connecticut
$14.4M +$16.6M +762,317 New
HMC
11
Harvard Management Company
Massachusetts
$12.8M – – –
Vanguard Group
12
Vanguard Group
Pennsylvania
$10.6M +$1.17M +53,830 +11%
CC
13
Commodore Capital
New York
$9.74M – – –
SG
14
StepStone Group
California
$9.06M – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$4.34M +$287K +13,176 +6%
State Street
16
State Street
Massachusetts
$4.08M +$713K +32,734 +18%
Northern Trust
17
Northern Trust
Illinois
$2.65M +$361K +16,583 +13%
JRP
18
Jasper Ridge Partners
California
$841K +$21.8K +1,000 +2%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$750K +$111K +5,107 +15%
Charles Schwab
20
Charles Schwab
California
$674K +$29K +1,332 +4%
TD Asset Management
21
TD Asset Management
Ontario, Canada
$669K +$108K +4,970 +16%
N
22
Nuveen
North Carolina
$580K +$224K +10,273 +50%
Morgan Stanley
23
Morgan Stanley
New York
$572K +$591K +27,132 +885%
Wells Fargo
24
Wells Fargo
California
$354K +$405K +18,595 +24,149%
Allspring Global Investments
25
Allspring Global Investments
North Carolina
$326K +$376K +17,254 New
1
2 3

TNYA Hedge Fund Activity: Q4 2021 in Review

47 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q4 2021, worth a combined $668M — down 3.7% from $693M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new TNYA positions and 7 closed out — a net gain of 1 holder — while 22 added to existing stakes and 2 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $13.5M. The largest seller was Woodline Partners, exiting entirely with an estimated $3.1M sold.

  • 47 institutional investors held Tenaya Therapeutics (TNYA) as of Q4 2021, unchanged from Q3 2021.
  • Funds reported $668M of Tenaya Therapeutics stock for Q4 2021, down 3.7% quarter-over-quarter.
  • 8 funds opened new Tenaya Therapeutics positions in Q4 2021 and 7 closed out, a net change of +1 holder.
  • The largest Tenaya Therapeutics buyer in Q4 2021 was Fidelity Investments, an estimated $13.5M added.
  • The largest Tenaya Therapeutics seller in Q4 2021 was Woodline Partners, an estimated $3.1M sold.

Based on aggregated 13F filings for Q4 2021.